or Try an Advanced Search...

    ETF Components for PBE - PowerShares Dynamic Biotech & Genome


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    BMRN B -1.60 5.44
    NBIX C -0.41 5.23
    REGN C 0.32 5.00
    VRTX C 0.20 4.98
    GILD F 0.91 4.95
    AMGN B 2.35 4.93
    TECH F -0.14 4.91
    BIIB F 2.03 4.73
    MNKD D 2.45 3.29
    CPRX B -1.37 3.21
    EXEL A 0.13 3.16
    COLL C 0.20 3.15
    UTHR A 0.42 3.15
    HALO D 2.20 3.09
    TGTX D -1.50 3.06
    CLDX D -1.43 2.92
    PTCT F 2.55 2.84
    VCEL B -0.27 2.83
    DVAX D 4.06 2.74
    IONS D -0.32 2.69
    BPMC C -2.31 2.68
    QGEN D 1.34 2.66
    ITCI A 0.51 2.52
    XENE D -1.07 2.45
    RGEN D 0.05 2.39
    MYGN D -0.05 2.34
    FOLD D 2.71 2.24
    VCYT F 1.30 2.22
    EYPT D 0.86 2.21
    ACAD F -1.46 1.95

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Chemical Compounds Monoclonal Antibodies Monoclonal Antibody S&P 500 Disorders Nasdaq 100 Organic Compounds Pain Cardiovascular Disease Clinical Development Diabetes Immunology Inflammation Life Sciences Prostate Cancer Treatment Of Cancer
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic

    Recent News for PowerShares Dynamic Biotech & Genome & its Holdings

    Date Stock Title
    Apr 20 TECH Peter Schiff Mocks 'Bitcoiners' After Halving Event, Asks If They're 'Throwing Parties:' 'Hodlers Will Experience A Halving Of Their Net Worths'
    Apr 19 VRTX Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
    Apr 19 ITCI How Is The Market Feeling About Intra-Cellular Therapies?
    Apr 19 VRTX Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
    Apr 19 TECH Understanding Netflix, Disney Market Maneuvers: Decoding The Streaming Strategy
    Apr 19 FOLD When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
    Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
    Apr 19 TECH Think Trading In Your iPhone Helps Keep Planet Green? Turns Out There Are Plenty Of Dirty Secrets, Report Reveals
    Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
    Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
    Apr 19 TECH 'No Real Use Case:' Cybertruck's Lead Engineer Asks What GM's 'CrabWalk' Feature Is Good For After Revealing Tesla 'Played' With Idea
    Apr 19 TECH Meta AI Chatbot Poses As Parent In NYC Facebook Group, Claims To Have Disabled Child In School: Report
    Apr 19 TECH Management Expert Warns Elon Musk Faces 'CEO Overload' After Tesla Layoffs Reportedly Leave Him Overseeing 35 Key Personnel
    Apr 19 TECH Google's DeepMind to Lead Unified AI Charge as Company Seeks to Outpace Microsoft
    Apr 19 TECH Tesla Recalls Over 3,800 Cybertrucks Citing Unintended Acceleration Risk
    Apr 19 TECH European EV Makers Say Climate Goals At Risk As Electric Car Market Is No Longer Growing: 'People Just Don't Earn Enough To Buy These...'
    Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
    Apr 19 VRTX Is Vertex Pharmaceuticals Stock a Millionaire Maker?
    Apr 19 TECH Rivian's Newest Dealership In Texas Will Be Just 14 Miles From Tesla's Gigafactory, Google Data Shows
    Apr 19 TECH Netflix Won't Reveal Quarterly Subscriber Numbers Anymore: Co-CEO Greg Peters Says This Is What Motivated The Change
    The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Invesco Powershares Genetic Engineering Inter 10 Index Genome
    Back to the Main PBE Page...